Somatic Alterations and Tumor Mutational Burden (TMB) in Patients with Metastatic Colorectal Cancer (mCRC) Treated with FOLFiRI Plus Bevacizumab or Cetuximab (Fire-3 Trial)Arndt Stahler,Sebastian Stintzing,Jobst C. von Einem,C. Benedikt Westphalen,Nicole Kraemer,Marlies Michl,Dominik Paul Modest,Ludwig Fischer von Weikersthal,Thomas Decker,Alexander Kiani,Tobias Heintges,Christoph Kahl,Frank Kullmann,Werner Scheithauer,Markus Moehler,Ursula Vehling-Kaiser,Thomas Kirchner,Andreas Jung,Volker HeinemannONCOLOGY RESEARCH AND TREATMENT(2020)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要